Announcement
13 May 2026

The ATOM Coalition supports clinician training to strengthen breast cancer care in Mongolia

The UICCled ATOM Coalition delivered a national multidisciplinary breast cancer management course for health workers in Mongolia to strengthen breast cancer care and support treatment delivery across the country. 

In March 2026, the UICC-led ATOM Coalition, in collaboration with the American Society of Clinical Oncology (ASCO), a Coalition partner and UICC member, organised a multidisciplinary breast cancer management course that notably involved supporting the implementation of updated breast cancer clinical guidelines.

The course brought together more than 180 clinicians from 19 districts across the country, helping expand workforce capacity beyond the capital, in line with national efforts to decentralise cancer services. The course was one of the larger multidisciplinary cancer management courses implemented by ASCO, and the first of its kind in Mongolia.

The course built on revised national breast cancer clinical guidelines that were updated in May 2025. In Mongolia, public reimbursement is directly linked to medicines listed in clinical guidelines, which made the update essential to enabling access to treatment.

Through the updated guidelines, breast cancer patients across the country are expected to benefit from bestinclass standards of care. Early observations following the course indicate first steps toward standardised clinical pathways that support a faster, safer and more effective use of cancer medicines, with the first multidisciplinary teams being established only 24 hours after the course in some participating institutions.

Last update

Wednesday 13 May 2026

Share this page

Related content

Close up of a hand of a hospital patient receiving IV antibiotics

Andrew Whitehead of UICC partner Bristol Myers Squibb writes about how equitable access to innovative cancer treatments cannot rest on a single intervention, but rather depends on stronger health systems spanning financing, diagnostics, workforce capacity and patient engagement.

Cary Adams speaking at the ATOM launch

The UICC-led ATOM Coalition has seen encouraging progress since its launch on 20 May 2022 in expanding access to quality assured cancer medicines and diagnostics in LLMICs. The next phase focuses on country uptake, readiness, and impact on people living with cancer